Insulin resistance in the liver: Deficiency or excess of insulin?

被引:45
作者
Bazotte, Roberto B. [1 ]
Silva, Lorena G. [1 ]
Schiavon, Fabiana P. M. [1 ]
机构
[1] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil
关键词
hyperinsulinism; insulin resistance; liver glucose production; liver lipogenesis; nonparenchymal liver cells; obesity; periportal hepatocytes; perivenous hepatocytes; type; 2; diabetes; NONALCOHOLIC FATTY LIVER; RAT-LIVER; HEPATOCYTE HETEROGENEITY; GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; METABOLISM; ZONATION; GLUCOSE; DYSFUNCTION;
D O I
10.4161/15384101.2014.947750
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In insulin-resistant states (obesity, pre-diabetes, and type 2 diabetes), hepatic production of glucose and lipid synthesis are heightened in concert, implying that insulin deficiency and insulin excess coexists in this setting. The fact that insulin may be inadequate or excessive at any one point in differing organs and tissues has many biologic ramifications. In this context the concept of metabolic compartmentalization in the liver is offered herein as one perspective of this paradox. In particular, we focus on the hypothesis that insulin resistance accentuates differences in periportal and perivenous hepatocytes, namely periportal glucose production and perivenous lipid synthesis. Subsequently, excessive production of glucose and accumulation of lipids could be expected in the livers of patients with obesity and insulin resistance. Overall, in this review, we provide our integrative perspective regarding how excessive production of glucose in periportal hepatocytes and accumulation of lipids in perivenous hepatocytes interact in insulin resistant states.
引用
收藏
页码:2494 / 2500
页数:7
相关论文
共 84 条
[21]   Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study [J].
DeFronzo, R. A. ;
Banerji, M. A. ;
Bray, G. A. ;
Buchanan, T. A. ;
Clement, S. ;
Henry, R. R. ;
Kitabchi, A. E. ;
Mudaliar, S. ;
Musi, N. ;
Ratner, R. ;
Reaven, P. ;
Schwenke, D. C. ;
Stentz, F. D. ;
Tripathy, D. .
DIABETOLOGIA, 2010, 53 (03) :435-445
[22]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[23]   Mechanisms of non-apoptotic programmed cell death in diabetes and heart failure [J].
Dorn, Gerald W., II .
CELL CYCLE, 2010, 9 (17) :3442-3448
[24]  
EILERS F, 1995, HISTOCHEM CELL BIOL, V103, P293, DOI 10.1007/BF01457414
[25]   Regional heterogeneities in the production of uric acid from adenosine in the bivascularly perfused rat liver [J].
Fernandes, TRL ;
Suzuki-Kemmelmeier, F ;
Ishii-Iwamoto, EL ;
Constantin, J ;
Bracht, A .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 195 (1-2) :207-217
[26]   Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment [J].
Fruci, Barbara ;
Giuliano, Stefania ;
Mazza, Angela ;
Malaguarnera, Roberta ;
Belfiore, Antonino .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11) :22933-22966
[27]   PP2A inhibition results in hepatic insulin resistance despite Akt2 activation [J].
Galbo, Thomas ;
Perry, Rachel J. ;
Nishimura, Erica ;
Samuel, Varman T. ;
Quistorff, Bjorn ;
Shulman, Gerald I. .
AGING-US, 2013, 5 (10) :770-781
[28]   Lipid-induced hepatic insulin resistance [J].
Galbo, Thomas ;
Shulman, Gerald I. .
AGING-US, 2013, 5 (08) :582-583
[29]   HETEROGENEOUS (POSITIONAL) EXPRESSION OF HEPATIC GLUTAMINE-SYNTHETASE - FEATURES, REGULATION AND IMPLICATIONS FOR HEPATOCARCINOGENESIS [J].
GEBHARDT, R ;
GAUNITZ, F ;
MECKE, D .
ADVANCES IN ENZYME REGULATION, VOL 34, 1994, 34 :27-56
[30]   METABOLIC ZONATION OF THE LIVER - REGULATION AND IMPLICATIONS FOR LIVER-FUNCTION [J].
GEBHARDT, R .
PHARMACOLOGY & THERAPEUTICS, 1992, 53 (03) :275-354